Prevalence of COVID-19 among patients with rheumatic diseases: The need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al
Academic Article
Publication Date:
2020
Iris type:
1.1 Articolo in rivista
Keywords:
antirheumatic agents; arthritis; biological therapy
List of contributors:
Monti, S.; Montecucco, C.
Published in: